Charts
From 02/05/2022 our Markets Data content will no longer be free to read. To continue to get full access, subscribe now and receive 25% off.
Equities

Gillette India Ltd

GILLETTE:NSI

Gillette India Ltd

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (INR)8,514.30
  • Today's Change49.25 / 0.58%
  • Shares traded4.32k
  • 1 Year change+39.34%
  • Beta0.3325
Data delayed at least 15 minutes, as of Oct 01 2024 05:30 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Gillette India Limited is an India-based company, which is engaged in manufacturing and selling of branded packaged fast moving consumer goods in the grooming and oral care businesses. The Company’s segment includes grooming segment, which produces and sells shaving system and cartridges, blades, toiletries, and components; and oral care segment, which produces and sells toothbrushes and oral care products. Its product portfolio includes razors, blades, styler and shaving gel, shaving cream, and aftershave. Its razors include Gillette Guard Shaving Razor, Gillette Body, and Fusion Razor, and 7 O'clock Super Platinum Blades. Its blades include Wilkinson Razor Blades, Non-slip rubber grip, 7 O'clock Super Stainless Blades, and Gillette Vector 3 Razor Blades. Its brands include GilletteLabs, SkinGuard Sensitive, Fusion5, MACH3, Disposable Razor, Guard3, and Styler. Its shaving gel, shaving cream and after shave products include Gillette Series Ultra Comfort Tube Shave Gel, and more.

  • Revenue in INR (TTM)26.33bn
  • Net income in INR4.12bn
  • Incorporated1984
  • Employees571.00
  • Location
    Gillette India LtdLink House 3, Bahadur Shah Zafar MargMUMBAI 400099IndiaIND
  • Phone+91 2 228266000
  • Fax+91 2 266939696
  • Websitehttps://www.gillette.co.in/en-in
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
PALTAC Corp683.77bn12.48bn163.87bn2.24k13.291.0010.040.2397337.16337.1618,479.424,462.722.3819.925.25519,160,000.004.344.697.508.397.497.681.821.941.43--0.0023.994.332.567.200.8661-10.836.69
Pola Orbis Holdings Inc100.86bn5.75bn192.88bn4.05k34.242.0018.321.9144.0744.07773.43755.160.84171.8810.5242,339,100.004.825.375.566.1881.8482.845.736.273.21--0.0003124.314.21-6.96-15.562.8712.16-8.25
Jyothy Labs Ltd28.12bn3.75bn200.07bn2.94k53.15--46.957.1210.2210.2276.65--------9,553,653.00--11.16--14.5949.9643.6013.3310.14--505.02--51.5010.908.7454.1112.49-1.473.13
Fancl Corp64.63bn4.90bn218.63bn1.28k40.724.2130.203.3868.5168.51904.24663.011.082.989.1186,027,430.008.207.9810.409.6366.9968.587.587.002.82--0.0052.357.03-1.9777.730.4219-7.932.53
Kobayashi Pharmaceutical Co Ltd101.84bn8.19bn254.50bn3.53k31.612.0620.552.50184.09184.092,307.552,821.320.65422.674.7448,943,410.005.268.016.4110.1854.7256.458.0412.242.21--0.005433.194.330.70371.582.4529.678.88
Lion Corp240.52bn11.93bn259.44bn7.55k22.481.5710.171.0872.0272.021,451.451,032.180.85843.765.8154,107,680.004.795.637.048.9345.3047.605.596.451.20--0.096331.013.312.88-33.34-10.609.215.39
Hengan International Group Company Ltd279.67bn35.66bn267.38bn24.00k8.981.305.710.9562.882.8822.5819.910.49354.018.681,128,851.006.297.7013.6015.9134.8737.1412.7514.791.1012.230.495565.995.092.9945.46-5.9215.95-9.05
Gillette India Limited26.33bn4.12bn288.53bn571.0067.2028.4958.3710.96126.35126.35808.08298.071.412.738.86--21.9820.4737.9133.0358.1753.4915.6414.451.0463.130.0000573.856.307.1815.7510.24-2.2815.39
Kose Corp185.61bn8.58bn292.01bn7.56k37.151.9418.921.57255.46255.465,524.984,892.200.84821.227.2441,709,980.004.24--5.41--69.99--5.00--2.78--0.0358--3.90---37.87------
Emami Ltd36.59bn7.38bn327.13bn3.29k44.43--35.478.9416.9216.9283.81--------11,123,460.00--20.43--27.9168.0865.5620.1718.75--52.01--53.895.065.8513.1319.00-21.8514.87
Giant Biogene Holding Co Ltd53.29bn21.13bn394.40bn1.51k24.347.5018.327.401.981.985.026.440.76492.9631.084,250,456.0030.24--36.89--82.74--39.53--3.62--0.0002--49.05--44.88------
Proya Cosmetics Co Ltd122.74bn16.67bn399.86bn2.97k28.998.69--3.263.453.4525.4111.511.474.2040.403,459,794.0020.3315.5428.5821.6168.7666.5813.8812.832.48--0.176130.1539.4530.4146.0632.97-4.8042.52
Data as of Oct 01 2024. Currency figures normalised to Gillette India Ltd's reporting currency: Indian Rupee INR

Institutional shareholders

11.16%Per cent of shares held by top holders
HolderShares% Held
Life Insurance Corporation of India (Investment Portfolio)as of 30 Jun 20231.71m5.26%
Aditya Birla Sun Life Amc Ltd. (Investment Management)as of 31 Jul 2024729.36k2.24%
ICICI Prudential Asset Management Co. Ltd.as of 31 Jul 2024384.50k1.18%
Nippon Life India Asset Management Ltd. (Invt Mgmt)as of 30 Jun 2024380.45k1.17%
quant Money Managers Ltd.as of 31 Jul 202494.00k0.29%
UTI Asset Management Co. Ltd. (Investment Management)as of 31 Jul 202481.58k0.25%
Dimensional Fund Advisors LPas of 04 Jul 202473.35k0.23%
Sundaram Asset Management Co. Ltd.as of 31 Jul 202467.15k0.21%
Bajaj Finserv Asset Management Ltd.as of 30 Jun 202457.45k0.18%
WhiteOak Capital Asset Management Ltd.as of 30 Jun 202454.56k0.17%
More ▼
Data from 30 Jun 2024 - 08 Aug 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.